Hansoh BioMedical R&D Company

Related records

Trials (42)

• A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
• A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)
• A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects
• A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
• A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
• A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
• A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
• A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)
• A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer
• A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
• A Study of HS-20110 in Participants With Advanced Solid Tumors
• A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer
• A Study of HS-20122 in Patients With Advanced Solid Tumors
• A Study of HS-20124 in Patients with Advanced Solid Tumors
• A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis
• A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy
• A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
• A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
• A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
• A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women